Related Experiment Video
Updated: Feb 13, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing
Matthew M Fleming1, Fangfang Liu2,3, Yawei Zhang2,4
1Section of General Surgery, Trauma, and Surgical Critical Care, Department of Surgery, Yale School of Medicine, 330 Cedar Street, BB310, New Haven, CT, 06519, USA.
Background:
The Model for End-Stage Liver Disease (MELD) score and ascites correlate with surgical morbidity and mortality. However, the MELD score does not account for ascites. We sought to evaluate whether the MELD score accurately risk stratifies patients with ascites.
Methods:
We analyzed the American College of Surgeons National Surgical Quality Improvement Program (2005-2014) to examine the risk-adjusted morbidity and mortality of cirrhotic patients with and without ascites undergoing colectomy for diverticulitis. Patients were stratified by MELD score, and the presence of ascites and outcomes were compared between patients with and without ascites to the reference group of low MELD and no ascites. Multivariable logistic regression was used to control for demographic factors and comorbidities.
Results:
A total of 16,877 colectomies were analyzed. For each MELD stratum, patients with ascites have increased risk of complications compared to those without ascites (P < 0.05 unless indicated): low MELD ascites OR 1.13, P = 0.69, moderate MELD no ascites OR 1.37, moderate MELD ascites OR 2.06, high MELD no ascites OR 1.93, and high MELD ascites OR 3.54. These trends hold true for mortality: low MELD ascites OR 2.91, P = 0.063, moderate MELD no ascites OR 1.47, moderate MELD ascites OR 5.62, high MELD no ascites OR 3.04, and high MELD ascites OR 9.91.
Conclusion:
Ascites predicts an increased risk for postoperative morbidity and mortality for cirrhotic patients undergoing colectomy for all MELD classifications. These findings suggest that the MELD score significantly underestimates postoperative risk as it does not account for ascites.
Insights
The Model for End-Stage Liver Disease (MELD) score underestimates surgical risk in cirrhotic patients with ascites. Ascites significantly increases postoperative morbidity and mortality, necessitating its inclusion in risk assessment for liver disease patients.
Area of Science:
- Hepatology
- Surgical Outcomes
- Risk Stratification
Background:
- The Model for End-Stage Liver Disease (MELD) score is used to assess surgical risk in patients with liver disease.
- Ascites, a common complication of cirrhosis, is not incorporated into the MELD score.
- The current MELD score may not accurately stratify surgical risk for patients with ascites.
Purpose of the Study:
- To evaluate the accuracy of the MELD score in risk stratifying cirrhotic patients with ascites undergoing colectomy.
- To determine if ascites independently predicts increased morbidity and mortality in this patient population.
Main Methods:
- Analysis of the American College of Surgeons National Surgical Quality Improvement Program database (2005-2014).
- Inclusion of cirrhotic patients undergoing colectomy for diverticulitis, stratified by MELD score and presence of ascites.
- Multivariable logistic regression to control for demographic factors and comorbidities.
Main Results:
- Ascites was associated with increased postoperative morbidity and mortality across all MELD score strata.
- For high MELD patients, ascites increased morbidity odds by 3.54 and mortality odds by 9.91.
- Even low MELD patients with ascites showed increased mortality risk (OR 2.91).
Conclusions:
- Ascites is a significant independent predictor of increased postoperative morbidity and mortality in cirrhotic patients undergoing colectomy.
- The MELD score underestimates surgical risk because it does not account for the presence of ascites.
- Clinical risk assessment for cirrhotic patients should incorporate the presence of ascites.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Stages of Infection
Stages of Sleep
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Stages of General Anesthesia
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

